Andere Sprachen Creo Medical Group PLC

Aktien

A2DH40

GB00BZ1BLL44

CREO

Markt geschlossen - London S.E. Andere Börsenplätze 17:35:06 26.04.2024			% 5 Tage	% 1. Jan.
36,25 ^GBX	0,00 %		+4,32 %	-21,20 %

24.04.	ActiveOps Umsatz steigt; Sancus Umsatz springt	AN
01.03.	Creo Medical Group plc gibt Update zur Mikrowellen-Lungenablation bekannt	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

ActiveOps sales up; Sancus turnover jumps	24.04.
Creo Medical says NHS case study reveals significant efficiencies from Speedboat technology	24.04.
EARNINGS AND TRADING: Dar Global celebrates "outstanding" year	01.03.
Creo Medical Group plc Announces Microwave Lung Ablation Update	01.03.
Creo Medical Group expands reach of Speedboat UltraSlim; announces tie-up with Abu Dhabi university	12.02.
Creo Medical ends "pivotal" 2023 year with clear path to cashflow breakeven	12.02.
Creo Medical makes "considerable strides" toward 2025 break-even goal	07.02.
Creo Medical partners with Khalifa University in Abu Dhabi	05.02.
Creo Medical Group plc Announces Strategic Collaboration with Khalifa University of Science and Technology	05.02.
Creo unveils product in APAC; Unilever hires director	31.01.
Creo Medical Group plc Announces Continued Progress on the Phased Market Release of Its Latest Device, Speedboat® UltraSlim	31.01.
Creo Medical's Speedboat UlstraSlim device used in Latin America	10.01.
Creo Medical's SpeedBoat UltraSlim successfully used in US	15.12.
Creo Medical Group plc Announces First Use of Speedboat UltraSlim in the USA	15.12.
Good Energy says ZapMap expands into mainland Europe	13.12.
Creo Medical Group PLC Announces the Initiation of Its Commercial Launch of Speedboat Ultraslim	13.12.
Creo Medical Group reveals good growth prospects at Capital Markets Day - Proactive Research Analyst	27.11.
Creo Medical CEO "very happy with where we are at the moment"	13.11.
Creo Medical Wins US FDA Nod for Medical Endoscopy Device	01.11.
Creo Medical Group plc Receives 510(K) Clearance from the Us Food & Drug Administration for Its Speedboat Ultraslim Device	01.11.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Creo Medical Group PLC

Aktien

A2DH40

GB00BZ1BLL44

CREO

Andere Sprachen

Filter